No current UK marketing authorisation was identified for KPV, BPC-157 or TB-500 as medicines for wound healing, inflammation, tissue recovery, gut disorders or cosmetic treatment
Avoid injecting into areas that are tender, bruised, red, or hardened , and do not use areas with scars or stretch marks
For most patients, noespecially with slow dose escalation
Why this is also about patient care This topic is not only about reimbursement
239 Studies have demonstrated that GLP-1 mediates several beneficial extrapancreatic actions on both tissues which either express GLP-1R or do not, 11 and clinical trials have found that some GLP-1-mimetic-based therapies alleviate T2D-associated cardiovascular diseases